Description

S 23, 40mg

Mechanism of medicine action:

S 23 operates by selectively targeting androgen receptors in skeletal muscle and bone tissue. Upon binding to these receptors, S 23 induces a series of anabolic processes, including increased protein synthesis and muscle hypertrophy, while simultaneously inhibiting catabolic processes that lead to muscle breakdown. This mechanism helps to enhance both muscle mass and strength without crucial androgenic side effects in other tissues, such as the prostate.

Indications:

S 23 is primarily indicated for use in the enhancement of muscle mass and strength. It is often utilized by bodybuilders and athletes looking to improve performance, promote body recomposition (loss of fat while gaining muscle), and accelerate recovery times post-exercise. In a clinical setting, S 23 may be investigated for its potential benefits in treating muscle-wasting conditions or other anabolic insufficiencies.

Contraindications:

S 23 is contraindicated in individuals with known hypersensitivity to the drug or any of its components. It is not recommended for use in pregnant or nursing women due to the potential for adverse effects on fetal development or lactation. Additionally, individuals with a history of androgen-related disorders should exercise caution.

Precautions:

Before initiating treatment with S 23, it is crucial to evaluate the individual’s overall health status, particularly liver and kidney function. Patients should be monitored for potential side effects, including hormonal imbalances, cardiovascular issues, and liver toxicity. Regular blood tests may be warranted to assess cholesterol levels, liver enzymes, and hormone levels during the treatment period.

Drug interactions:

S 23 may interact with other medications metabolized by hepatic enzymes. Caution should be exercised when combined with medications that affect liver function or other anabolic agents, as this could potentially amplify the effects or side effects of S 23. A thorough review of the patient’s medication history is essential to identify any potential interactions.

Dosage:

S-23 is typically used in cycles of 8 to 12 weeks for men and 4 to 6 weeks for women, although these durations may vary based on individual preferences and specific cycle requirements. For men, the recommended dosage is 20-30 mg daily, ideally taken 30-40 minutes before workouts and after meals, throughout the cycling period. Women should take a lower dosage of 5-10 mg daily, also preferably 30-40 minutes before workouts and after meals, within their shorter cycle duration.

Injection Site Care & Technique:

To ensure safe and comfortable administration of injectable products:

• Warm the vial to body temperature before use
• Use a sterile 25G–27G needle and syringe
• Inject slowly into the muscle to minimize tissue irritation
• Massage the area gently after injection
• Rotate injection sites regularly
• Avoid injecting into inflamed or previously used areas
• Store product upright and avoid excessive agitation

Storage:

Store in a dark, dry place, at room temperature. Do not refrigerate. Keep out of reach of children.